S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 97.5 TWD -0.51% Market Closed
Market Cap: 11.7B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCI Pharmtech Inc
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Interest Income Expense
-NT$181k
CAGR 3-Years
84%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
YungShin Global Holding Corp
TWSE:3705
Interest Income Expense
NT$284.3m
CAGR 3-Years
265%
CAGR 5-Years
44%
CAGR 10-Years
20%
Formosa Laboratories Inc
TWSE:4746
Interest Income Expense
-NT$826.3m
CAGR 3-Years
N/A
CAGR 5-Years
-63%
CAGR 10-Years
-60%
ScinoPharm Taiwan Ltd
TWSE:1789
Interest Income Expense
NT$53.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lotus Pharmaceutical Co Ltd
TWSE:1795
Interest Income Expense
NT$506.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Standard Chem & Pharm Co Ltd
TWSE:1720
Interest Income Expense
NT$130.1m
CAGR 3-Years
N/A
CAGR 5-Years
27%
CAGR 10-Years
26%
No Stocks Found

SCI Pharmtech Inc
Glance View

Market Cap
11.7B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
47.61 TWD
Overvaluation 51%
Intrinsic Value
Price
S

See Also

What is SCI Pharmtech Inc's Interest Income Expense?
Interest Income Expense
-181k TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Interest Income Expense amounts to -181k TWD.

What is SCI Pharmtech Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
84%

The average annual Interest Income Expense growth rates for SCI Pharmtech Inc have been 84% over the past three years .

Back to Top